05:07 PM EST, 11/05/2024 (MT Newswires) -- Globus Medical ( GMED ) reported Q3 non-GAAP earnings Tuesday of $0.83 per diluted share, up from $0.57 a year earlier.

Analysts polled by Capital IQ expected $0.65.

Net sales for the quarter ended Sept. 30 were $625.7 million, up from $383.6 million a year earlier.

Analysts surveyed by Capital IQ expected $604.8 million.

The company said it now expects 2024 non-GAAP EPS to be between $2.90 and $3.00 and revenue to be between $2.49 billion and $2.50 billion.

The previous guidance was for non-GAAP EPS of $2.80 to $2.90 and revenue of $2.47 billion and $2.49 billion.

Analysts polled by Capital IQ expect $2.86 and $2.48 billion, respectively.

Price: 75.99, Change: +1.11, Percent Change: +1.48